Clinical Trials Browser

Phase 2 × Lung Neoplasms × bryostatin 1 × Clear all

NCT00005849 2013-02-11

Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms